DearTRANS

Genome data Analysis

WX

Biomarker Prediction

AI-Powered

Target Discovery

DearDTI

Molecule Selection

MolEQ

Lead Optimization

AI-Powered

Drug Design

The AI Platform For Drug Discovery

Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new drugs.

Our Technology Dr.UG

Pipeline

What we can do is...

Deargen’s A.I technology is being applied to various new drug development treatment strategies.

Learn More Our Pipeline

PROTAC

ADC

EPITOPE

AGONIST

INHIBITOR

Our Team

We make it together

We realize Precision Medicine together with experts in Deep learning, Software, Biology and Bioinformatics. Our brilliant Avengers team acts faster than anyone else and consistently moves to face new challenges.

Meet Our Teams

"Let's make a together"

Kilsoo Kang / CEO

Partners

Corporate Partnership

Scientific Collaboration

Contact

Email

contact@deargen.me

Phone

+82 70 4335 7236

FAX

Seoul Office (Research Institute)

Address

Deargen, 15th floor, Dongwon F&B, 60, Mabang-ro, Seocho-gu, Seoul, Republic of Korea

Daejeon Office

R1846, 18F, 136, Cheongsa-ro, Seo-gu, Daejeon, Republic of Korea

U.S. Office

4185 SILVER PEAK PKWY, SUITE A, SUWANEE, GA, 30024, USA

iDear Center

11F, 27, Dongtancheomdansaneop 1-ro, Hwaseong-si, Gyeonggi-do, Republic of Korea

ⓒ 2021 Deargen Inc.

KOR
EN